Table 1.
Long-term outcomes of multicenter prospective trials of bariatric surgery in adolescents
| Author (year) | Study | Followed-up/enrolled patient (n) | Age (yr) | BMI at the baseline (kg/m2) | Change in BMI (%) | Remission rate of comorbidity (%) | ||
|---|---|---|---|---|---|---|---|---|
| T2DM | Hypertension | Dyslipidemia | ||||||
| Olbers et al. (2017)16 | AMOS | 81/81 | 16.5 (13–18) | 45.5±6.1 | –29 | 100 | 92 | 83 |
| Inge et al. (2017)17 | FABS 5+ | 58/58 | 17.1 (13–21) | 58.5±10.1 | –29 | 88 | 76 | 64 |
| Inge et al. (2019)18 | Teen-LABS | 149/161 | 17.0 (<18) | 54±10 | –26 | 86 | 68 | - |
Values are presented as median (range) or mean±standard deviation.
BMI, body mass index; T2DM, type 2 diabetes mellitus; AMOS, Swedish Adolescent Morbid Obesity Surgery; FABS 5+, Follow-up of Adolescent Bariatric Surgery at 5 Plus Years; Teen-LABS, Teen-Longitudinal Assessment of Bariatric Surgery.